RVMD
NASDAQ
US
Revolution Medicines, Inc. - Common Stock
$99.12
▲ +$0.48
(+0.49%)
Vol 1.3M
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$15.4B
ROE
-25.9%
Margin
-2833.9%
D/E
16.06
Beta
1.01
52W
$29–$82
Wall Street Consensus
27 analysts · Apr 202611
Strong Buy
15
Buy
1
Hold
0
Sell
0
Strong Sell
96.3%
Buy Rating
Price Chart
Similar Stocks
INSM
Insmed Inc
$37.1B
NTRA
Natera Inc
$31.7B
BIIB
Biogen Inc
P/E 16.0
$25.8B
UTHR
United Therapeutics Corp
P/E 16.5
$21.0B
MRNA
Moderna Inc
$11.5B
INCY
Incyte Corp
P/E 16.3
$19.4B
SMMT
Summit Therapeutics Inc
$13.0B
BBIO
BridgeBio Pharma Inc
$14.7B
NBIX
Neurocrine Biosciences Inc
P/E 33.0
$14.1B
MDGL
Madrigal Pharmaceuticals Inc
$13.2B
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-1.61 | $-1.86 | $-0.25 |
| Sep 2025 | $-1.45 | $-1.61 | $-0.16 |
| Jun 2025 | $-1.16 | $-1.31 | $-0.15 |
| Mar 2025 | $-1.11 | $-1.13 | $-0.02 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -33.5% | -33.5% | -33.5% | -25.9% | -25.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -2833.9% | -2833.9% | -2833.9% | -2833.9% | -2833.9% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 13.14 | 0.00 | 0.00 | 0.00 | 16.06 | 16.06 |
| Current Ratio | 11.79 | 11.79 | 11.79 | 11.79 | 8.05 | 8.05 |
Key Ratios
ROA (TTM)
-20.8%
P/S (TTM)
1330.62
P/B
3.6
EPS (TTM)
$-2.73
CF/Share
$-3.25
52W High
$81.97
52W Low
$29.17
$29.17
52-Week Range
$81.97
How does RVMD compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
RVMD valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1330.6
▲
10255%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
3.6
▲
45%
above
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
RVMD profitability vs Biotechnology peers
ROE
-25.9%
▲
62%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-2833.9%
▼
888%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-20.8%
▲
56%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
RVMD financial health vs Biotechnology peers
D/E ratio
16.1
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
8.1
▲
81%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.0
▲
4%
above
peers
(1.0)
vs Peers
vs Industry
Less volatile
RVMD fundamentals radar
RVMD
Peer median
Industry
RVMD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
RVMD vs peers: key metrics
Latest News
No related news yet